Vasaprostane, lyophilizate 60 mcg 49.5 mg 10 pcs

Microcirculatory disordersThe treatment of chronic obliterating arterial diseases of stages III and IV.

Indications

Treatment of chronic obliterating diseases of the arteries of stages III and IV.

Pharmacological effect

Vasodilator, antiaggregant.

Special instructions

During treatment with Vazaprostan, patients with signs of renal and heart failure should limit the volume of fluid to 50-100 ml/day.

Active ingredient

Alprostadil

Composition

1 ampoule contains alprostadil (in the form of alpha-cyclodextrin) 60 mcg;

Contraindications

– chronic heart failure in the stage of decompensation;
– acute myocardial infarction and post-infarction period for 6 months;
– severe heart rhythm disturbances;
– acute circulatory failure (shock, vascular collapse);
– severe arterial hypotension (systolic blood pressure less than 90 mm Hg);
– severe liver dysfunction;
– peptic ulcer of the stomach and duodenum;
– hypersensitivity to the drug.

Side Effects

From the cardiovascular system: palpitations, arterial hypotension, headache; in isolated cases – increased frequency of angina attacks, development of pulmonary edema, and symptoms of heart failure.

Interaction

With simultaneous use, Vazaprostan may enhance the hypotensive effect of antihypertensive drugs, peripheral vasodilators, and antianginal drugs.

Overdose

Symptoms: decreased blood pressure, skin hyperemia, weakness.

Storage conditions

The drug should be stored at a temperature not exceeding 25°C.

Shelf life

4 years

Manufacturer

IDT Biology GmbH, Germany